Literature DB >> 15562820

Circulating IGF-1 and its role in cancer: lessons from the IGF-1 gene deletion (LID) mouse.

Shoshana Yakar1, Patricia Pennisi, Hong Zhao, Yang Zhang, Derek LeRoith.   

Abstract

Recent epidemiological studies have suggested a statistical connection between serum IGF-1 levels in the upper quartile of the normal range and the relative risk of developing certain cancers. Our studies have focused on mouse models where circulating IGF-1 levels are reduced, while tissue expression of IGF-1 is normal. These mice show a lower risk for the development of colon and breast cancers and metastases when compared with control mice, and lend support to the hypothesis that circulating IGF-1 may be linked to cancer cell growth.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15562820

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  9 in total

Review 1.  Diabetes, Obesity, and Breast Cancer.

Authors:  Chifei Kang; Derek LeRoith; Emily J Gallagher
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

Review 2.  Class II G protein-coupled receptors and their ligands in neuronal function and protection.

Authors:  Bronwen Martin; Rakel Lopez de Maturana; Randall Brenneman; Tom Walent; Mark P Mattson; Stuart Maudsley
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

3.  Circulating IGF-1 promotes prostate adenocarcinoma via FOXO3A/BIM signaling in a double-transgenic mouse model.

Authors:  Shuang Wang; Ning Wang; Bin Yu; Mingxing Cao; Yanlong Wang; Yuqi Guo; Yanli Zhang; Ping Zhang; Xiao Yu; Shujing Wang; Li Zeng; Bin Liang; Xin Li; Yingjie Wu
Journal:  Oncogene       Date:  2019-07-16       Impact factor: 9.867

Review 4.  Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality.

Authors:  Emily Jane Gallagher; Derek LeRoith
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

5.  The GH/IGF-1 axis in a critical period early in life determines cellular DNA repair capacity by altering transcriptional regulation of DNA repair-related genes: implications for the developmental origins of cancer.

Authors:  Andrej Podlutsky; Marta Noa Valcarcel-Ares; Krysta Yancey; Viktorija Podlutskaya; Eszter Nagykaldi; Tripti Gautam; Richard A Miller; William E Sonntag; Anna Csiszar; Zoltan Ungvari
Journal:  Geroscience       Date:  2017-02-23       Impact factor: 7.713

6.  Glucose metabolism disorders in cancer patients in a Chinese population.

Authors:  Ya-Shi Zhan; Lie Feng; Shao-Hui Tang; Wan-Geng Li; Meng Xu; Tian-Fu Liu; You-Fen Zhou; Yu-Lin Ma; Yun Zhang; Xian-Ming Pu
Journal:  Med Oncol       Date:  2009-03-05       Impact factor: 3.064

Review 7.  Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights.

Authors:  Federica Biello; Francesca Platini; Francesca D'Avanzo; Carlo Cattrini; Alessia Mennitto; Silvia Genestroni; Veronica Martini; Paolo Marzullo; Gianluca Aimaretti; Alessandra Gennari
Journal:  Biomolecules       Date:  2021-01-19

Review 8.  Pathophysiological Link between Insulin Resistance and Adrenal Incidentalomas.

Authors:  Jordan A Higgs; Alyssa P Quinn; Kevin D Seely; Zeke Richards; Shad P Mortensen; Cody S Crandall; Amanda E Brooks
Journal:  Int J Mol Sci       Date:  2022-04-14       Impact factor: 6.208

9.  PICK1 deficiency impairs secretory vesicle biogenesis and leads to growth retardation and decreased glucose tolerance.

Authors:  Birgitte Holst; Kenneth L Madsen; Anna M Jansen; Chunyu Jin; Mattias Rickhag; Viktor K Lund; Morten Jensen; Vikram Bhatia; Gunnar Sørensen; Andreas N Madsen; Zhichao Xue; Siri K Møller; David Woldbye; Klaus Qvortrup; Richard Huganir; Dimitrios Stamou; Ole Kjærulff; Ulrik Gether
Journal:  PLoS Biol       Date:  2013-04-23       Impact factor: 8.029

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.